Page 5 - Afirma Genomic Sequencing Classifier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Afirma genomic sequencing classifier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Afirma Genomic Sequencing Classifier Today - Breaking & Trending Today

Veracyte, Inc. (NASDAQ:VCYT) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have received an average rating of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on […] ....

Hong Kong , William Blair , Harbor Capital Advisors Inc , Morgan Stanley , Russell Investments Group Ltd , Needham Company , International Assets Investment Management , Bergankdv Wealth Management , Hong Kong Ltd , Veracyte Inc , Get Free Report , Marketbeat Ratings , Investments Group , Kong Ltd , Capital Advisors , Stock Down , Get Free , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Immunoscore Colon Cancer , Veracyte Daily , Nasdaq Vcyt ,

Veracyte, Inc. (NASDAQ:VCYT) Receives $30.20 Consensus Target Price from Analysts

Veracyte, Inc. (NASDAQ:VCYT) Receives $30.20 Consensus Target Price from Analysts
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , William Blair , Morgan Stanley , International Assets Investment Management , Goldman Sachs Group , Russell Investments Group Ltd , Hong Kong Ltd , Veracyte Inc , Veracyte Company Profile , Harbor Capital Advisors Inc , Bergankdv Wealth Management , Get Free Report , Investments Group , Kong Ltd , Capital Advisors , Trading Down , Get Free , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Immunoscore Colon Cancer , Veracyte Daily ,

Champlain Investment Partners LLC Increases Position in Veracyte, Inc. (NASDAQ:VCYT)

Champlain Investment Partners LLC lifted its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 0.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,922,345 shares of the biotechnology company’s stock after purchasing an additional 3,615 shares during the […] ....

New Zealand General , New Zealand , William Blair , Champlain Investment Partners , Exchange Commission , Wellington Management Group , Bank Julius Baer Co , Vanguard Group Inc , Blackrock Inc , Ltd Zurich , Veracyte Inc , Morgan Stanley , Goldman Sachs Group , Needham Company , Free Report , Investment Partners , Julius Baer , Management Group , State Street Corp , Street Corp , Get Free Report , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test ,

Veracyte, Inc. (NASDAQ:VCYT) Given Average Rating of "Moderate Buy" by Brokerages

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven brokerages that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have assigned a buy recommendation to the […] ....

William Blair , Royal Bank , Mercer Global Advisors Inc , Veracyte Inc , Needham Company , Veracyte Company Profile , Walleye Capital , Manufacturers Life Insurance Company , Goldman Sachs Group , Get Free Report , Marketbeat Ratings , Global Advisors , Get Free , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Immunoscore Colon Cancer , Veracyte Daily , Nasdaq Vcyt ,

Needham & Company LLC Cuts Veracyte (NASDAQ:VCYT) Price Target to $30.00

Veracyte (NASDAQ:VCYT – Free Report) had its price objective lowered by Needham & Company LLC from $35.00 to $30.00 in a report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the company. Stephens reiterated an overweight […] ....

William Blair , William Blair Investment Management , Goldman Sachs Group , Needham Company , Veracyte Inc , Deutsche Bank , Morgan Stanley , Fiera Capital Corp , Free Report , Moderate Buy , Get Free Report , Blair Investment Management , Capital Corp , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Immunoscore Colon Cancer , Veracyte Daily , Nasdaq Vcyt , Lower Price Target , Needham Company Llc ,